Anti-™202/ ™EM202 monoclonal antibody

Anti-™202/ ™EM202 antibody for FACS & in-vivo assay

Target products collectionGo to ™EM202/™EM202 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1827-Ab-1/ GM-Tg-hg-MP1827-Ab-2Anti-Human ™EM202 monoclonal antibodyHuman
GM-Tg-rg-MP1827-Ab-1/ GM-Tg-rg-MP1827-Ab-2Anti-Rat ™EM202 monoclonal antibodyRat
GM-Tg-mg-MP1827-Ab-1/ GM-Tg-mg-MP1827-Ab-2Anti-Mouse ™EM202 monoclonal antibodyMouse
GM-Tg-cynog-MP1827-Ab-1/ GM-Tg-cynog-MP1827-Ab-2Anti-Cynomolgus/ Rhesus macaque ™EM202 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1827-Ab-1/ GM-Tg-felg-MP1827-Ab-2Anti-Feline ™EM202 monoclonal antibodyFeline
GM-Tg-cang-MP1827-Ab-1/ GM-Tg-cang-MP1827-Ab-2Anti-Canine ™EM202 monoclonal antibodyCanine
GM-Tg-bovg-MP1827-Ab-1/ GM-Tg-bovg-MP1827-Ab-2Anti-Bovine ™EM202 monoclonal antibodyBovine
GM-Tg-equg-MP1827-Ab-1/ GM-Tg-equg-MP1827-Ab-2Anti-Equine ™EM202 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1827-Ab-1/ GM-Tg-hg-MP1827-Ab-2; GM-Tg-rg-MP1827-Ab-1/ GM-Tg-rg-MP1827-Ab-2;
GM-Tg-mg-MP1827-Ab-1/ GM-Tg-mg-MP1827-Ab-2; GM-Tg-cynog-MP1827-Ab-1/ GM-Tg-cynog-MP1827-Ab-2;
GM-Tg-felg-MP1827-Ab-1/ GM-Tg-felg-MP1827-Ab-2; GM-Tg-cang-MP1827-Ab-1/ GM-Tg-cang-MP1827-Ab-2;
GM-Tg-bovg-MP1827-Ab-1/ GM-Tg-bovg-MP1827-Ab-2; GM-Tg-equg-MP1827-Ab-1/ GM-Tg-equg-MP1827-Ab-2
Products NameAnti-™EM202 monoclonal antibody
Formatmab
Target Name™EM202
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-™EM202 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ™202/ ™EM202 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1827
    Target Name™EM202
    Gene ID338949,73893,691306,698497,785001,100063521
    Gene Symbol and Synonyms4930425N13Rik,™EM202
    Uniprot AccessionA6NGA9
    Uniprot Entry Name™202_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000187806
    Target ClassificationN/A

    The target: ™EM202, gene name: ™EM202, also named as . Predicted to be integral component of membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.